You are here: Industry Insights > Generic

News List

Teva’s generic EpiPen launch stalls months after approval biospectrumasia
February 02, 2019
The short supply represents a missed opportunity for Teva to compete with Mylan in a roughly $750 million a year US market
FDA approves first generic Advair Diskus worldpharmanews
February 01, 2019
The U.S. Food and Drug Administration approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in...
Cipla receives approval for Pfizer’s Depo-Provera biospectrumasia
January 29, 2019
It is a progestin indicated only for the prevention of pregnancy
Dr. Reddy's brings Propofol injectable emulsion in US market biospectrumasia
January 28, 2019
Dr. Reddy’s Propofol Injectable Emulsion, USP is available in 10 mg/mL vials for Single Patient Use Only
Final verdict on finasteride: Safe, effective prevention for prostate cancer worldpharmanews
January 24, 2019
Finasteride, a generic hormone-blocking drug, was found to reduce the risk of prostate cancer by 25 percent in the landmark Prostate Cancer Prevention Trial (PCPT).
Lupin receives US FDA approval for Levothyroxine Sodium tabs expressbpd
January 23, 2019
The drug is indicated for the treatment of hypothyroidism and pituitary thyrotropin supression
Generic version of seizure drug Sabril gets FDA approval europeanpharmaceuticalreview
January 21, 2019
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA…
Hetero launches generic Lapatinib under brand name ‘Hertab’ in India expressbpd
January 14, 2019
The drug is made available in two SKUs, each consisting of 30 tablets and 150 tablets
Lupin gets US FDA nod for generic schizophrenia drug expressbpd
January 08, 2019
The drug is a generic version os Sunovion Pharmaceuticals’ Latuda tablets
FDA lets generics makers keep their legal shield, handing embattled industry a win fiercepharma
January 02, 2019
Five years after proposing a rule that would have given generic drug makers responsibility for their own drug labels—a move that would have exposed them to more lawsuits—the FDA has changed its mind.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page